Search

Your search keyword '"Woodworth, Kate R."' showing total 182 results
Start Over Author "Woodworth, Kate R."
182 results on '"Woodworth, Kate R."'

2. Outcomes up to age 36 months after congenital Zika virus infection—U.S. states

Author

Neelam, Varsha, Woodworth, Kate R., Chang, Daniel J., Roth, Nicole M., Reynolds, Megan R., Akosa, Amanda, Carr, Christopher P., Anderson, Kayla N., Mulkey, Sarah B., DeBiasi, Roberta L., Biddle, Cara, Lee, Ellen H., Elmore, Amanda L., Scotland, Sarah J., Sowunmi, Similoluwa, Longcore, Nicole D., Ahmed, Muhammad, Langlois, Peter H., Khuwaja, Salma, Browne, Shea Elizabeth, Lind, Leah, Shim, Kyoo, Gosciminski, Michael, Blumenfeld, Rachel, Khuntia, Shreya, Halai, Umme-Aiman, Locklear, Autumn, Chan, Mary, Willabus, Teri’, Tonzel, Julius, Marzec, Natalie S., Barreto, Nianest Alers, Sanchez, Connie, Fornoff, Jane, Hale, Shelby, Nance, Amy, Iguchi, Lisa, Adibhatla, Sowmya N., Potts, Emily, Schiffman, Elizabeth, Raman, Devin, McDonald, Morgan F., Stricklin, Brandi, Ludwig, Elizabeth, Denson, Lindsay, Contreras, Dianna, Romitti, Paul A., Ferrell, Emily, Marx, Meghan, Signs, Kimberly, Cook, Amie, Leedom, Vinita Oberoi, Beauregard, Suzann, Orantes, Lucia C., Cronquist, Laura, Roush, Lesley, Godfred-Cato, Shana, Gilboa, Suzanne M., Meaney-Delman, Dana, Honein, Margaret A., Moore, Cynthia A., and Tong, Van T.

Published
2024
Full Text
View/download PDF

4. Pregnancy and infant outcomes following SARS-CoV-2 infection in pregnancy during delta variant predominance – Surveillance for Emerging Threats to Pregnant People and Infants

Author

Reeves, Emily L., Neelam, Varsha, Carlson, Jeffrey M., Olsen, Emily O., Fox, Charise J., Woodworth, Kate R., Nestoridi, Eirini, Mobley, Evan, Montero Castro, Shaila, Dzimira, Paula, Sokale, Ayomide, Sizemore, Lindsey, Hall, Aron J., Ellington, Sascha, Cohn, Amanda, Gilboa, Suzanne M., and Tong, Van T.

Published
2024
Full Text
View/download PDF

5. Frequency of Children Diagnosed with Perinatal Hepatitis C, United States, 2018-2020

Author

Newton, Suzanne M., Woodworth, Kate R., Chang, Daniel, Sizemore, Lindsey, Wingate, Heather, Pinckney, Leah, Osinski, Anthony, Orkis, Lauren, Reynolds, Bethany D., Carpentieri, Cynthia, Halai, Umme-Aiman, Lyu, Caleb, Longcore, Nicole, Thomas, Nadia, Wills, Aprielle, Akosa, Amanda, Olsen, Emily O'Malley, Panagiotakopoulos, Lakshmi, Thompson, Nicola D., Gilboa, Suzanne M., and Tong, Van T.

Subjects
United States. Centers for Disease Control and Prevention -- Analysis, Viral antibodies -- Analysis, Hepatitis C virus -- Analysis, Infants -- Analysis, Infection -- Prevention, RNA -- Analysis, Disease transmission -- Prevention, Public health -- Analysis, Antibodies -- Analysis, Health
Abstract

Hepatitis C virus (HCV) can be transmitted perinatally (1). Rates of acute HCV infection have increased recently (2), but few children perinatally exposed to HCV are tested and referred to [...]

Published
2024

10. The Advisory Committee on Immunization Practices Interim Recommendation for Use of Pfizer-BioNTech COVID-19 Vaccine in Children Aged 5–11 Years — United States, November 2021

Author

Woodworth, Kate R., Moulia, Danielle, Collins, Jennifer P., Hadler, Stephen C., Jones, Jefferson M., Reddy, Sujan C., Chamberland, Mary, Campos-Outcalt, Doug, Morgan, Rebecca L., Brooks, Oliver, Talbot, H. Keipp, Lee, Grace M., Bell, Beth P., Daley, Matthew F., Mbaeyi, Sarah, Dooling, Kathleen, and Oliver, Sara E.

Published
2021

12. Preterm birth among pregnant persons with severe acute respiratory syndrome Coronavirus 2 infection

Author

Newton, Suzanne M., Reeves, Emily L., O’Malley Olsen, Emily, Woodworth, Kate R., Farr, Sherry L., Galang, Romeo R., Reynolds, Megan R., Harvey, Elizabeth, Shi, Jing, Nestoridi, Eirini, Barton, Jerusha, Ngo, Van P., Lush, Mamie, Longcore, Nicole D., Dzimira, Paula, Im, Lucille K., Sokale, Ayomide, Siebman, Samantha, Delgado López, Camille, Chen, Tiffany, Mobley, Evan L., Khuwaja, Salma, Romitti, Paul A., Fredette, Carolyn, Ellis, Esther M., Silcox, Kristin, Hall, Aron J., Azziz-Baumgartner, Eduardo, Gilboa, Suzanne M., Shapiro-Mendoza, Carrie K., and Tong, Van T.

Published
2022
Full Text
View/download PDF

14. The Advisory Committee on Immunization Practices’ Interim Recommendation for Use of Pfizer-BioNTech COVID-19 Vaccine in Adolescents Aged 12–15 Years — United States, May 2021

Author

Wallace, Megan, Woodworth, Kate R., Gargano, Julia W., Scobie, Heather M., Blain, Amy E., Moulia, Danielle, Chamberland, Mary, Reisman, Nicole, Hadler, Stephen C., MacNeil, Jessica R., Campos-Outcalt, Doug, Morgan, Rebecca L., Daley, Matthew F., Romero, José R., Talbot, H. Keipp, Lee, Grace M., Bell, Beth P., and Oliver, Sara E.

Published
2021

15. Hepatitis C Virus Testing Among Perinatally Exposed Children: 2018 to 2020.

Author

Woodworth, Kate R., Distler, Samantha, Chang, Daniel J., Luong, Jackie, Newton, Suzanne, Akosa, Amanda, Orkis, Lauren, Reynolds, Bethany, Carpentieri, Cynthia, Willabus, Teri, Osinski, Anthony, Shephard, Hanna, Halai, Umme-Aiman, Lyu, Caleb, Sizemore, Lindsey, Sandul, Amy, and Van T. Tong

Subjects
*HEPATITIS C diagnosis, *HEPATITIS C transmission, *HEPATITIS transmission, *COMMUNICABLE diseases, *VIRAL antibodies, *RESEARCH funding, *DESCRIPTIVE statistics, *CHI-squared test, *DISEASE prevalence, *LONGITUDINAL method, *VERTICAL transmission (Communicable diseases), *HEPATITIS C, *MEDICAL screening, *COMPARATIVE studies, *DATA analysis software, *PREGNANCY complications, *CHILDREN
Abstract

OBJECTIVE: To assess the frequency of hepatitis C virus (HCV) testing among a population-based cohort of perinatally exposed children and identify factors associated with testing. METHODS: Using a population-based surveillance cohort of perinatally exposed children born from 2018 to 2020 from 4 US jurisdictions (Georgia; Massachusetts; Allegheny County, Pennsylvania; and Los Angeles County, California), we describe the frequency, timing, and type of HCV testing among children and identify characteristics associated with having an HCV test result by the age of 2 to 3 years. Data were obtained from electronic laboratory reporting, vital records, and medical records. RESULTS: Of 803 perinatally exposed children, 7 (1%) died before the age of 24 months. Of 796 children, health departments were unable to find medical records or laboratory reports for 181 (23%). Among those with medical record abstraction at 24 months or testing reported before the age of 3 years (n = 615), 50% had an HCV test. The majority (70% of those tested) were tested for HCV antibodies at the age of 18 months or later, although 9% had an HCV nucleic acid test at ages 2 to <6 months. No characteristics examined were found to be significantly associated with having testing reported. CONCLUSIONS: In this surveillance report, we identify the gaps in current testing among children perinatally exposed to hepatitis C. Provider education and resources for health departments for follow-up and linkage to care can improve the identification of children requiring treatment, a vital piece of HCV elimination. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

16. Recurrent SARS-CoV-2 RNA Detection after COVID-19 Illness Onset during Pregnancy

Author

Griffin, Isabel, Woodworth, Kate R., Galang, Romeo R., Burkel, Veronica K., Neelam, Varsha, Siebman, Samantha, Barton, Jerusha, Manning, Susan E., Aveni, Kathryn, Longcore, Nicole D., Harvey, Elizabeth M., Ngo, Van, Mbotha, Deborah, Chicchelly, Sarah, Lush, Mamie, Eckert, Valorie, Dzimira, Paula, Sokale, Ayomide, Valencia-Prado, Miguel, Azziz-Baumgartner, Eduardo, MacNeil, Adam, Gilboa, Suzanne M., and Tong, Van T.

Subjects
RNA -- Statistics -- Health aspects, Pregnant women -- Statistics -- Health aspects, Health
Abstract

Detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) RNA in respiratory specimens that recurs over extended time intervals might indicate viral RNA persistence, continued viral replication, reinfection, or sample [...]

Published
2022
Full Text
View/download PDF

17. Detection of SARS-CoV-2 in Neonatal Autopsy Tissues and Placenta

Author

Reagan-Steiner, Sarah, Bhatnagar, Julu, Martines, Roosecelis B., Milligan, Nicholas S., Gisondo, Carly, Williams, Frank B., Lee, Elizabeth, Estetter, Lindsey, Bullock, Hannah, Goldsmith, Cynthia S., Fair, Pamela, Hand, Julie, Richardson, Gillian, Woodworth, Kate R., Oduyebo, Titilope, Galang, Romeo R., Phillips, Rebecca, Belyaeva, Elizaveta, Yin, Xiao-Ming, Meaney-Delman, Dana, Uyeki, Timothy M., Roberts, Drucilla J., and Zaki, Sherif R.

Subjects
Infants -- Patient outcomes, Perinatal infection -- Risk factors -- Complications and side effects -- Case studies, Premature birth -- Case studies, Health
Abstract

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection during pregnancy is associated with severe maternal coronavirus disease (COVID-19) and preterm birth and may increase the risk for other complications of [...]

Published
2022
Full Text
View/download PDF

18. Birth and Infant Outcomes Following Laboratory-Confirmed SARS-CoV-2 Infection in Pregnancy — SET-NET, 16 Jurisdictions, March 29–October 14, 2020

Author

CDC COVID-19 Response Pregnancy and Infant Linked Outcomes Team, Woodworth, Kate R., Olsen, Emily O’Malley, Neelam, Varsha, Lewis, Elizabeth L., Galang, Romeo R., Oduyebo, Titilope, Aveni, Kathryn, Yazdy, Mahsa M., Harvey, Elizabeth, Longcore, Nicole D., Barton, Jerusha, Fussman, Chris, Siebman, Samantha, Lush, Mamie, Patrick, Paul H., Halai, Umme-Aiman, Valencia-Prado, Miguel, Orkis, Lauren, Sowunmi, Similoluwa, Schlosser, Levi, Khuwaja, Salma, Read, Jennifer S., Hall, Aron J., Meaney-Delman, Dana, Ellington, Sascha R., Gilboa, Suzanne M., and Tong, Van T.

Published
2020

20. A Preparedness Model for Mother–Baby Linked Longitudinal Surveillance for Emerging Threats

Author

Woodworth, Kate R., Reynolds, Megan R., Burkel, Veronica, Gates, Cymone, Eckert, Valorie, McDermott, Catherine, Barton, Jerusha, Wilburn, Amanda, Halai, Umme-Aiman, Brown, Catherine M., Bocour, Angelica, Longcore, Nicole, Orkis, Lauren, Lopez, Camille Delgado, Sizemore, Lindsey, Ellis, Esther M., Schillie, Sarah, Gupta, Neil, Bowen, Virginia B., Torrone, Elizabeth, Ellington, Sascha R., Delaney, Augustina, Olson, Samantha M., Roth, Nicole M., Whitehill, Florence, Zambrano, Laura D., Meaney-Delman, Dana, Fehrenbach, S. Nicole, Honein, Margaret A., Tong, Van T., and Gilboa, Suzanne M.

Published
2021
Full Text
View/download PDF

23. Pregnancy and Infant Outcomes Following SARS-CoV-2 Infection in Pregnancy during Delta Variant Predominance – Surveillance for Emerging Threats to Pregnant People and Infants

Author

Reeves, Emily L., primary, Neelam, Varsha, additional, Olsen, Emily O., additional, Carlson, Jeffrey M., additional, Fox, Charise J., additional, Woodworth, Kate R., additional, Nestoridi, Eirini, additional, Mobley, Evan, additional, Castro, Shaila Montero, additional, Dzimira, Paula, additional, Sokale, Ayomide, additional, Sizemore, Lindsey, additional, Hall, Aron J., additional, Ellington, Sascha, additional, Cohn, Amanda, additional, Gilboa, Suzanne, additional, and Tong, Van T., additional

Published
2023
Full Text
View/download PDF

24. Outcomes up to age 36 months after congenital Zika virus infection—U.S. states

Author

Neelam, Varsha, primary, Woodworth, Kate R., additional, Chang, Daniel J., additional, Roth, Nicole M., additional, Reynolds, Megan R., additional, Akosa, Amanda, additional, Carr, Christopher P., additional, Anderson, Kayla N., additional, Mulkey, Sarah B., additional, DeBiasi, Roberta L., additional, Biddle, Cara, additional, Lee, Ellen H., additional, Elmore, Amanda L., additional, Scotland, Sarah J., additional, Sowunmi, Similoluwa, additional, Longcore, Nicole D., additional, Ahmed, Muhammad, additional, Langlois, Peter H., additional, Khuwaja, Salma, additional, Browne, Shea Elizabeth, additional, Lind, Leah, additional, Shim, Kyoo, additional, Gosciminski, Michael, additional, Blumenfeld, Rachel, additional, Khuntia, Shreya, additional, Halai, Umme-Aiman, additional, Locklear, Autumn, additional, Chan, Mary, additional, Willabus, Teri’, additional, Tonzel, Julius, additional, Marzec, Natalie S., additional, Barreto, Nianest Alers, additional, Sanchez, Connie, additional, Fornoff, Jane, additional, Hale, Shelby, additional, Nance, Amy, additional, Iguchi, Lisa, additional, Adibhatla, Sowmya N., additional, Potts, Emily, additional, Schiffman, Elizabeth, additional, Raman, Devin, additional, McDonald, Morgan F., additional, Stricklin, Brandi, additional, Ludwig, Elizabeth, additional, Denson, Lindsay, additional, Contreras, Dianna, additional, Romitti, Paul A., additional, Ferrell, Emily, additional, Marx, Meghan, additional, Signs, Kimberly, additional, Cook, Amie, additional, Leedom, Vinita Oberoi, additional, Beauregard, Suzann, additional, Orantes, Lucia C., additional, Cronquist, Laura, additional, Roush, Lesley, additional, Godfred-Cato, Shana, additional, Gilboa, Suzanne M., additional, Meaney-Delman, Dana, additional, Honein, Margaret A., additional, Moore, Cynthia A., additional, and Tong, Van T., additional

Published
2023
Full Text
View/download PDF

25. Substance Use Among Persons with Syphilis During Pregnancy--Arizona and Georgia, 2018-2021

Author

Carlson, Jeffrey M., Tannis, Ayzsa, Woodworth, Kate R., Reynolds, Megan R., Shinde, Neha, Anderson, Breanne, Hobeheidar, Keivon, Praag, Aisha, Campbell, Kristen, Carpentieri, Cynthia, Willabus, Teri, Burkhardt, Elizabeth, Torrone, Elizabeth, O'Callaghan, Kevin P., Miele, Kathryn, Meaney-Delman, Dana, Gilboa, Suzanne M., Olsen, Emily O'Malley, and Tong, Van T.

Subjects
Penicillin G, Genetic disorders, Syphilis, Pregnancy, Methamphetamine, Pregnant women, Substance abuse, Health
Abstract

Despite universal prenatal syphilis screening recommendations and availability of effective antibiotic treatment, syphilis prevalence during pregnancy and the incidence of congenital syphilis have continued to increase in the United States [...]

Published
2023

27. Notes from the Field: Autism Spectrum Disorder Among Children with Laboratory Evidence of Prenatal Zika Virus Exposure — Puerto Rico, 2023

Author

Roth, Nicole M., primary, Delgado-López, Camille, additional, Wiggins, Lisa D., additional, Muñoz, Nancy Nieves, additional, Mulkey, Sarah B., additional, Nieves-Ferrer, Leishla, additional, Woodworth, Kate R., additional, Rosario, Glorimar Meléndez, additional, Huertas, Mariam Marcano, additional, Moore, Cynthia A., additional, Tong, Van T., additional, Gilboa, Suzanne M., additional, and Valencia-Prado, Miguel, additional

Published
2023
Full Text
View/download PDF

28. Interim Recommendations of the Advisory Committee on Immunization Practices for Use of Moderna and Pfizer-BioNTech COVID-19 Vaccines in Children Aged 6 Months-5 Years--United States, June 2022

Author

Fleming-Dutra, Katherine E., Wallace, Megan, Moulia, Danielle L., Twentyman, Evelyn, Roper, Lauren E., Hall, Elisha, Link-Gelles, Ruth, Godfrey, Monica, Woodworth, Kate R., Anderson, Tara C., Rubis, Amy B., Shanley, Edwin, III, Jones, Jefferson M., Morgan, Rebecca L., Brooks, Oliver, Talbot, H. Keipp, Lee, Grace M., Bell, Beth P., Daley, Matthew, Meyer, Sarah, and Oliver, Sara E.

Subjects
United States. Food and Drug Administration, United States. Department of Health and Human Services, Pfizer Inc., Children's furniture -- Usage, Vaccines -- Usage, Pharmaceutical industry -- Usage, Health
Abstract

On June 28, 2022, this report was posted as an MMWR Early Release on the MMWR website (https://www.cdc.gov/mmwr). On June 17, 2022, the Food and Drug Administration (FDA) issued Emergency [...]

Published
2022

29. Leveraging automated approaches to categorize birth defects from abstracted birth hospitalization data.

Author

Newton, Suzanne M., Distler, Samantha, Woodworth, Kate R., Chang, Daniel, Roth, Nicole M., Board, Amy, Hutcherson, Hailee, Cragan, Janet D., Gilboa, Suzanne M., and Tong, Van T.

Abstract

Background: The Surveillance for Emerging Threats to Pregnant People and Infants Network (SET‐NET) collects data abstracted from medical records and birth defects registries on pregnant people and their infants to understand outcomes associated with prenatal exposures. We developed an automated process to categorize possible birth defects for prenatal COVID‐19, hepatitis C, and syphilis surveillance. By employing keyword searches, fuzzy matching, natural language processing (NLP), and machine learning (ML), we aimed to decrease the number of cases needing manual clinician review. Methods: SET‐NET captures International Classification of Diseases, 10th Revision, Clinical Modification (ICD‐10‐CM) codes and free text describing birth defects. For unstructured data, we used keyword searches, and then conducted fuzzy matching with a cut‐off match score of ≥90%. Finally, we employed NLP and ML by testing three predictive models to categorize birth defect data. Results: As of June 2023, 8326 observations containing data on possible birth defects were submitted to SET‐NET. The majority (n = 6758 [81%]) were matched to an ICD‐10‐CM code and 1568 (19%) were unable to be matched. Through keyword searches and fuzzy matching, we categorized 1387/1568 possible birth defects. Of the remaining 181 unmatched observations, we correctly categorized 144 (80%) using a predictive model. Conclusions: Using automated approaches allowed for categorization of 99.6% of reported possible birth defects, which helps detect possible patterns requiring further investigation. Without employing these analytic approaches, manual review would have been needed for 1568 observations. These methods can be employed to quickly and accurately sift through data to inform public health responses. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

30. SARS-CoV-2 During Omicron Variant Predominance Among Infants Born to People With SARS-CoV-2

Author

Gosdin, Lucas, primary, Chang, Daniel, additional, Olsen, Emily O’Malley, additional, Lewis, Elizabeth L., additional, Wingate, Heather, additional, Ojo, Kristen D., additional, Shephard, Hanna, additional, Sokale, Ayomide, additional, Mobley, Evan L., additional, Delgado-López, Camille, additional, Hall, Aron J., additional, Gilboa, Suzanne M., additional, Tong, Van T., additional, and Woodworth, Kate R., additional

Published
2023
Full Text
View/download PDF

31. Sudden Unexpected Infant Deaths: 2015–2020

Author

Shapiro-Mendoza, Carrie K., primary, Woodworth, Kate R., additional, Cottengim, Carri R., additional, Erck Lambert, Alexa B., additional, Harvey, Elizabeth M., additional, Monsour, Michael, additional, Parks, Sharyn E., additional, and Barfield, Wanda D., additional

Published
2023
Full Text
View/download PDF

32. Timing of Positive Hepatitis C Virus Test Results During and 1 Year Before Pregnancy

Author

Woodworth, Kate R., primary, Newton, Suzanne M., additional, Olsen, Emily O., additional, Tannis, Ayzsa, additional, Sizemore, Lindsey, additional, Wingate, Heather, additional, Orkis, Lauren, additional, Reynolds, Bethany, additional, Longcore, Nicole, additional, Thomas, Nadia, additional, Bocour, Angelica, additional, Wills, Aprielle, additional, Kim, Shin Y., additional, Panagiotakopoulos, Lakshmi, additional, Wester, Carolyn, additional, Delman Meaney, Dana, additional, Gilboa, Suzanne M., additional, and Tong, Van T., additional

Published
2022
Full Text
View/download PDF

34. Breast Milk Feeding of Infants at Birth Among People With Confirmed SARS-CoV-2 Infection in Pregnancy: SET-NET, 5 States, March 29, 2020–December 31, 2020

Author

Lewis, Elizabeth L., primary, Smoots, Ashley N., additional, Woodworth, Kate R., additional, Olsen, Emily O’Malley, additional, Roth, Nicole M., additional, Yazdy, Mahsa, additional, Shephard, Hanna, additional, Sizemore, Lindsey, additional, Wingate, Heather, additional, Dzimira, Paula, additional, Reynolds, Bethany, additional, Lush, Mamie, additional, Fuchs, Erika L., additional, Ojo, Kristen, additional, Siebman, Sam, additional, Hall, Aron J., additional, Azziz-Baumgartner, Eduardo, additional, Perrine, Cria, additional, Hsia, Jason, additional, Ellington, Sascha, additional, Tong, Van T., additional, and Gilboa, Suzanne M., additional

Published
2022
Full Text
View/download PDF

35. Pregnancy and infant outcomes by trimester of SARS‐CoV ‐2 infection in pregnancy– SET‐NET , 22 jurisdictions, January 25, 2020–December 31, 2020

Author

Neelam, Varsha, primary, Reeves, Emily L., additional, Woodworth, Kate R., additional, O'Malley Olsen, Emily, additional, Reynolds, Megan R., additional, Rende, Joy, additional, Wingate, Heather, additional, Manning, Susan E., additional, Romitti, Paul, additional, Ojo, Kristen D., additional, Silcox, Kristin, additional, Barton, Jerusha, additional, Mobley, Evan, additional, Longcore, Nicole D., additional, Sokale, Ayomide, additional, Lush, Mamie, additional, Delgado‐Lopez, Camille, additional, Diedhiou, Abdoulaye, additional, Mbotha, Deborah, additional, Simon, Wanda, additional, Reynolds, Bethany, additional, Hamdan, Tahani S., additional, Beauregard, Suzann, additional, Ellis, Esther M., additional, Seo, Jennifer Y., additional, Bennett, Amanda, additional, Ellington, Sascha, additional, Hall, Aron J., additional, Azziz‐Baumgartner, Eduardo, additional, Tong, Van T., additional, and Gilboa, Suzanne M., additional

Published
2022
Full Text
View/download PDF

37. Coronavirus Disease 2019 (COVID-19) Severity Among Women of Reproductive Age With Symptomatic Laboratory-Confirmed Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection by Pregnancy Status—United States, 1 January 2020–25 December 2021

Author

Strid, Penelope, primary, Zapata, Lauren B, additional, Tong, Van T, additional, Zambrano, Laura D, additional, Woodworth, Kate R, additional, Riser, Aspen P, additional, Galang, Romeo R, additional, Gilboa, Suzanne M, additional, and Ellington, Sascha R, additional

Published
2022
Full Text
View/download PDF

38. Birth and Infant Outcomes Following Laboratory-Confirmed SARS-CoV-2 Infection in Pregnancy — SET-NET, 16 Jurisdictions, March 29–October 14, 2020

Author

Woodworth, Kate R., Olsen, Emily O’Malley, Neelam, Varsha, Lewis, Elizabeth L., Galang, Romeo R., Oduyebo, Titilope, Aveni, Kathryn, Yazdy, Mahsa M., Harvey, Elizabeth, Longcore, Nicole D., Barton, Jerusha, Fussman, Chris, Siebman, Samantha, Lush, Mamie, Patrick, Paul H., Halai, Umme-Aiman, Valencia-Prado, Miguel, Orkis, Lauren, Sowunmi, Similoluwa, Schlosser, Levi, Khuwaja, Salma, Read, Jennifer S., Hall, Aron J., Meaney-Delman, Dana, Ellington, Sascha R., Gilboa, Suzanne M., Tong, Van T., Delaney, Augustina, Hsia, Jason, King, Kellianne, Perez, Mirna, Reynolds, Megan, Riser, Aspen, Rivera, Maria, Sancken, Christina, Sims, John, Smoots, Ashley, Snead, Margaret, Strid, Penelope, Yowe-Conley, Tineka, Zambrano, Laura, Zapata, Lauren, Manning, Susan, Burkel, Veronica, Akosa, Amanda, Bennett, Carolyne, Griffin, Isabel, Nahabedian, John, Newton, Suzanne, Roth, Nicole M., Shinde, Neha, Whitehouse, Erin, Chang, Daniel, Fox, Charise, Mohamoud, Yousra, and Whitehill, Florence

Subjects
Health (social science), Epidemiology, Health, Toxicology and Mutagenesis, Abortion, 01 natural sciences, 0302 clinical medicine, COVID-19 Testing, Health Information Management, Pregnancy, Infection control, 030212 general & internal medicine, Full Report, Young adult, Pregnancy Complications, Infectious, education.field_of_study, Obstetrics, Pregnancy Outcome, Gestational age, General Medicine, Premature birth, Premature Birth, Female, Coronavirus Infections, Adult, medicine.medical_specialty, Population, Pneumonia, Viral, Risk Assessment, 03 medical and health sciences, Betacoronavirus, Young Adult, medicine, Humans, 0101 mathematics, education, Pandemics, business.industry, Clinical Laboratory Techniques, SARS-CoV-2, Public health, 010102 general mathematics, Infant, Newborn, COVID-19, medicine.disease, Infectious Disease Transmission, Vertical, United States, Abortion, Spontaneous, business, Laboratories
Abstract

Pregnant women with coronavirus disease 2019 (COVID-19) are at increased risk for severe illness and might be at risk for preterm birth (1-3). The full impact of infection with SARS-CoV-2, the virus that causes COVID-19, in pregnancy is unknown. Public health jurisdictions report information, including pregnancy status, on confirmed and probable COVID-19 cases to CDC through the National Notifiable Diseases Surveillance System.* Through the Surveillance for Emerging Threats to Mothers and Babies Network (SET-NET), 16 jurisdictions collected supplementary information on pregnancy and infant outcomes among 5,252 women with laboratory-confirmed SARS-CoV-2 infection reported during March 29-October 14, 2020. Among 3,912 live births with known gestational age, 12.9% were preterm (

Published
2020

39. Update: Characteristics of Symptomatic Women of Reproductive Age with Laboratory-Confirmed SARS-CoV-2 Infection by Pregnancy Status — United States, January 22–October 3, 2020

Author

Zambrano, Laura D., Ellington, Sascha, Strid, Penelope, Galang, Romeo R., Oduyebo, Titilope, Tong, Van T., Woodworth, Kate R., Nahabedian, John F., Azziz-Baumgartner, Eduardo, Gilboa, Suzanne M., Meaney-Delman, Dana, Akosa, Amanda, Bennett, Carolyne, Burkel, Veronica, Chang, Daniel, Delaney, Augustina, Fox, Charise, Griffin, Isabel, Hsia, Jason, Krause, Katie, Lewis, Elizabeth, Manning, Susan, Mohamoud, Yousra, Newton, Suzanne, Neelam, Varsha, Olsen, Emily O’Malley, Perez, Mirna, Reynolds, Megan, Riser, Aspen, Rivera, Maria, Roth, Nicole M., Sancken, Christina, Shinde, Neha, Smoots, Ashley, Snead, Margaret, Wallace, Bailey, Whitehill, Florence, Whitehouse, Erin, and Zapata, Lauren

Subjects
Adult, medicine.medical_specialty, Health (social science), Adolescent, Epidemiology, Health, Toxicology and Mutagenesis, medicine.medical_treatment, Pneumonia, Viral, Prenatal care, 01 natural sciences, Risk Assessment, Severity of Illness Index, law.invention, 03 medical and health sciences, Betacoronavirus, Young Adult, 0302 clinical medicine, COVID-19 Testing, Health Information Management, law, Pregnancy, Severity of illness, Extracorporeal membrane oxygenation, medicine, Humans, 030212 general & internal medicine, Full Report, 0101 mathematics, Young adult, Pregnancy Complications, Infectious, Pandemics, Obstetrics, business.industry, Clinical Laboratory Techniques, SARS-CoV-2, 010102 general mathematics, COVID-19, General Medicine, medicine.disease, Intensive care unit, United States, Relative risk, Female, Symptom Assessment, Risk assessment, business, Coronavirus Infections, Laboratories
Abstract

Studies suggest that pregnant women might be at increased risk for severe illness associated with coronavirus disease 2019 (COVID-19) (1,2). This report provides updated information about symptomatic women of reproductive age (15-44 years) with laboratory-confirmed infection with SARS-CoV-2, the virus that causes COVID-19. During January 22-October 3, CDC received reports through national COVID-19 case surveillance or through the National Notifiable Diseases Surveillance System (NNDSS) of 1,300,938 women aged 15-44 years with laboratory results indicative of acute infection with SARS-CoV-2. Data on pregnancy status were available for 461,825 (35.5%) women with laboratory-confirmed infection, 409,462 (88.7%) of whom were symptomatic. Among symptomatic women, 23,434 (5.7%) were reported to be pregnant. After adjusting for age, race/ethnicity, and underlying medical conditions, pregnant women were significantly more likely than were nonpregnant women to be admitted to an intensive care unit (ICU) (10.5 versus 3.9 per 1,000 cases; adjusted risk ratio [aRR] = 3.0; 95% confidence interval [CI] = 2.6-3.4), receive invasive ventilation (2.9 versus 1.1 per 1,000 cases; aRR = 2.9; 95% CI = 2.2-3.8), receive extracorporeal membrane oxygenation (ECMO) (0.7 versus 0.3 per 1,000 cases; aRR = 2.4; 95% CI = 1.5-4.0), and die (1.5 versus 1.2 per 1,000 cases; aRR = 1.7; 95% CI = 1.2-2.4). Stratifying these analyses by age and race/ethnicity highlighted disparities in risk by subgroup. Although the absolute risks for severe outcomes for women were low, pregnant women were at increased risk for severe COVID-19-associated illness. To reduce the risk for severe illness and death from COVID-19, pregnant women should be counseled about the importance of seeking prompt medical care if they have symptoms and measures to prevent SARS-CoV-2 infection should be strongly emphasized for pregnant women and their families during all medical encounters, including prenatal care visits. Understanding COVID-19-associated risks among pregnant women is important for prevention counseling and clinical care and treatment.

Published
2020

41. SARS‐CoV‐2 infections among neonates born to pregnant people with SARS‐CoV‐2 infection: Maternal, pregnancy and birth characteristics

Author

Olsen, Emily O'Malley, primary, Roth, Nicole M., additional, Aveni, Kathryn, additional, Santos, Pauline, additional, Sizemore, Lindsey, additional, Halai, Umme‐Aiman, additional, Nestoridi, Eirini, additional, Barton, Jerusha Elana, additional, Mobley, Evan, additional, Siebman, Samantha, additional, Fussman, Chris, additional, Mbotha, Deborah, additional, Dzimira, Paula, additional, Silcox, Kristin M., additional, Khuwaja, Salma, additional, Roscom, Danacamile, additional, Lush, Mamie, additional, Chicchelly, Sarah, additional, Delgado‐López, Camille, additional, Schlosser, Levi, additional, Read, Jennifer, additional, Ellington, Sascha R., additional, Hall, Aron J., additional, Gilboa, Suzanne M., additional, Tong, Van T., additional, and Woodworth, Kate R., additional

Published
2022
Full Text
View/download PDF

42. Breastmilk feeding of infants at birth among people with confirmed SARS-CoV-2 infection in pregnancy — SET-NET, Five States, March 29, 2020–December 31, 2020

Author

Lewis, Elizabeth L., primary, Smoots, Ashley N., additional, Woodworth, Kate R., additional, Olsen, Emily O’Malley, additional, Roth, Nicole M., additional, Yazdy, Mahsa, additional, Shephard, Hanna, additional, Sizemore, Lindsey, additional, Wingate, Heather, additional, Dzimira, Paula, additional, Reynolds, Bethany, additional, Lush, Mamie, additional, Fuchs, Erika L., additional, Ojo, Kristen, additional, Siebman, Sam, additional, Hall, Aron J., additional, Azziz-Baumgartner, Eduardo, additional, Perrine, Cria, additional, Hsia, Jason, additional, Ellington, Sascha, additional, Tong, Van T., additional, and Gilboa, Suzanne M., additional

Published
2022
Full Text
View/download PDF

43. Identifying possible inaccuracy in reported birth head circumference measurements among infants in the US Zika Pregnancy and Infant Registry

Author

Roth, Nicole M., primary, Woodworth, Kate R., additional, Godfred‐Cato, Shana, additional, Delaney, Augustina M., additional, Olson, Samantha M., additional, Nahabedian, John F., additional, Reynolds, Megan R., additional, Jones, Abbey M., additional, Neelam, Varsha, additional, Valencia‐Prado, Miguel, additional, Delgado‐López, Camille, additional, Lee, Ellen H., additional, Ellis, Esther M., additional, Lake‐Burger, Heather, additional, Tonzel, Julius L., additional, Higgins, Cathleen A., additional, Chan, Ronna L., additional, Tong, Van T., additional, Gilboa, Suzanne M., additional, Cragan, Janet D., additional, Honein, Margaret A., additional, and Moore, Cynthia A., additional

Published
2022
Full Text
View/download PDF

45. Zika-Associated Birth Defects Reported in Pregnancies with Laboratory Evidence of Confirmed or Possible Zika Virus Infection — U.S. Zika Pregnancy and Infant Registry, December 1, 2015–March 31, 2018

Author

Roth, Nicole M., primary, Reynolds, Megan R., additional, Lewis, Elizabeth L., additional, Woodworth, Kate R., additional, Godfred-Cato, Shana, additional, Delaney, Augustina, additional, Akosa, Amanda, additional, Valencia-Prado, Miguel, additional, Lash, Maura, additional, Elmore, Amanda, additional, Langlois, Peter, additional, Khuwaja, Salma, additional, Tufa, Aifili, additional, Ellis, Esther M., additional, Nestoridi, Eirini, additional, Lyu, Caleb, additional, Longcore, Nicole D, additional, Piccardi, Monika, additional, Lind, Leah, additional, Starr, Sharon, additional, Johnson, Loletha, additional, Browne, Shea E., additional, Gosciminski, Michael, additional, Velasco, Paz E., additional, Johnson-Clarke, Fern, additional, Locklear, Autumn, additional, Chan, Mary, additional, Fornoff, Jane, additional, Toews, Karrie-Ann E., additional, Tonzel, Julius, additional, Marzec, Natalie S., additional, Hale, Shelby, additional, Nance, Amy E., additional, Willabus, Teri, additional, Contreras, Dianna, additional, Adibhatla, Sowmya N., additional, Iguchi, Lisa, additional, Potts, Emily, additional, Schiffman, Elizabeth, additional, Lolley, Katherine, additional, Stricklin, Brandi, additional, Ludwig, Elizabeth, additional, Garstang, Helentina, additional, Marx, Meghan, additional, Ferrell, Emily, additional, Moreno-Gorrin, Camille, additional, Signs, Kimberly, additional, Romitti, Paul, additional, Leedom, Vinita, additional, Martin, Brennan, additional, Castrodale, Louisa, additional, Cook, Amie, additional, Fredette, Carolyn, additional, Denson, Lindsay, additional, Cronquist, Laura, additional, Nahabedian, John F., additional, Shinde, Neha, additional, Polen, Kara, additional, Gilboa, Suzanne M., additional, Martin, Stacey W., additional, Cragan, Janet D., additional, Meaney-Delman, Dana, additional, Honein, Margaret A., additional, Tong, Van T., additional, and Moore, Cynthia A., additional

Published
2022
Full Text
View/download PDF

47. Pregnancy and infant outcomes by trimester of SARS‐CoV‐2 infection in pregnancy–SET‐NET, 22 jurisdictions, January 25, 2020–December 31, 2020.

Author

Neelam, Varsha, Reeves, Emily L., Woodworth, Kate R., O'Malley Olsen, Emily, Reynolds, Megan R., Rende, Joy, Wingate, Heather, Manning, Susan E., Romitti, Paul, Ojo, Kristen D., Silcox, Kristin, Barton, Jerusha, Mobley, Evan, Longcore, Nicole D., Sokale, Ayomide, Lush, Mamie, Delgado‐Lopez, Camille, Diedhiou, Abdoulaye, Mbotha, Deborah, and Simon, Wanda

Abstract

Objectives: We describe clinical characteristics, pregnancy, and infant outcomes in pregnant people with laboratory‐confirmed SARS‐CoV‐2 infection by trimester of infection. Study Design: We analyzed data from the Surveillance for Emerging Threats to Mothers and Babies Network and included people with infection in 2020, with known timing of infection and pregnancy outcome. Outcomes are described by trimester of infection. Pregnancy outcomes included live birth and pregnancy loss (<20 weeks and ≥20 weeks gestation). Infant outcomes included preterm birth (<37 weeks gestation), small for gestational age, birth defects, and neonatal intensive care unit admission. Adjusted prevalence ratios (aPR) were calculated for pregnancy and selected infant outcomes by trimester of infection, controlling for demographics. Results: Of 35,200 people included in this analysis, 50.8% of pregnant people had infection in the third trimester, 30.8% in the second, and 18.3% in the first. Third trimester infection was associated with a higher frequency of preterm birth compared to first or second trimester infection combined (17.8% vs. 11.8%; aPR 1.44 95% CI: 1.35–1.54). Prevalence of birth defects was 553.4/10,000 live births, with no difference by trimester of infection. Conclusions: There were no signals for increased birth defects among infants in this population relative to national baseline estimates, regardless of timing of infection. However, the prevalence of preterm birth in people with SARS‐CoV‐2 infection in pregnancy in our analysis was higher relative to national baseline data (10.0–10.2%), particularly among people with third trimester infection. Consequences of COVID‐19 during pregnancy support recommended COVID‐19 prevention strategies, including vaccination. [ABSTRACT FROM AUTHOR]

Published
2023
Full Text
View/download PDF

48. Population-Based Linked Longitudinal Surveillance of Pregnant People and Their Infants: A Critical Resource for Emerging, Re-Emerging, and Persistent Threats.

Author

Tong, Van T., Woodworth, Kate R., Blau, Erin, Shinde, Neha, Akosa, Amanda, Gilboa, Suzanne M., Meaney-Delman, Dana, Bromfield, Jaymie, Burkel, Veronica, Carlson, Jeffrey, Chang, Daniel, Fox, Charise, Gosdin, Lucas, King, Kellianne, Lewis, Elizabeth, Neelam, Varsha, Newton, Suzanne, Olsen, Emily, Rathore, Emmitt, and Reeves, Emily

Subjects
*PREVENTION of communicable diseases, *PUBLIC health surveillance, *HEALTH policy, *COVID-19, *HEALTH facilities, *COVID-19 vaccines, *PREGNANT women, *PUBLIC health, *DEPARTMENTS, *PREGNANCY complications, *QUALITY assurance, *VERTICAL transmission (Communicable diseases), *PREGNANCY
Abstract

Public health emergencies, from Zika to COVID-19, have underscored the importance of addressing the needs of pregnant people and their infants. Recent events have underlined the critical role of mother–infant-linked longitudinal surveillance to characterize and assess the impacts of emerging, re-emerging, and persistent threats, including infectious diseases, on these populations. In partnership with state, local, and territorial health departments, CDC's National Center on Birth Defects and Developmental Disabilities activated the Surveillance for Emerging Threats to Mothers and Babies Network (SET-NET) to capture information about pregnant people with laboratory-confirmed infection with SARS-CoV-2 (the virus that causes COVID-19) and their infants. SET-NET data were critical in recognizing the severe risks of COVID-19 during pregnancy, which ultimately informed clinical decisions and public health policy, specifically vaccine prioritization at the local, state, and national levels. This commentary describes the activation of SET-NET to monitor COVID-19 in pregnancy and highlights the experiences of health departments. We provide examples of how SET-NET findings informed COVID-19 prevention efforts and public health policy. Lastly, we identify opportunities to improve and advance surveillance efforts to protect the health of pregnant people and their infants in the United States from current and future threats. [ABSTRACT FROM AUTHOR]

Published
2023
Full Text
View/download PDF

49. Congenital cytomegalovirus surveillance in the United States.

Author

Raines, Kelley, Heitman, Kristen Nichols, Leung, Jessica, Woodworth, Kate R., Tong, Van T., Sugerman, David E., and Lanzieri, Tatiana M.

Abstract

Background: Congenital cytomegalovirus (cCMV) is not a nationally notifiable condition, and little is known about how U.S. health departments (HDs) currently conduct cCMV surveillance. Methods: We surveyed U.S. HDs that conduct cCMV surveillance or screening activities identified through a web‐based assessment. Meetings were held with each HD to enhance our understanding of survey responses. Results: Ten states are systematically collecting cCMV case data to track cCMV cases during early infancy and to provide resources and services to families. Cases are ascertained using cCMV diagnostic codes, reported diagnosis, or laboratory results. Data elements collected for each case include demographics (all 10 states), clinical signs (8 states), laboratory data (4 states), treatment (4 states), and long‐term outcomes (1 state). Annual number of cases reported by HDs ranged from 3 to 47 cases/year in seven states, which was much lower than the expected number of cCMV cases. All 10 HDs have the ability to analyze data collected and four disseminate findings. Major challenges of surveillance reported by HDs were lack of standardized case definitions, personnel constraints, and limited funding. Conclusions: A comprehensive account of cCMV disease burden is severely limited by low case ascertainment and paucity of data on long‐term outcomes. A standardized public health case definition for cCMV would improve consistency in measuring disease prevalence across jurisdictions and over time. Surveillance for cCMV has the potential to increase disease awareness and inform strategies to prevent cCMV‐associated disabilities. [ABSTRACT FROM AUTHOR]

Published
2023
Full Text
View/download PDF

50. Risk factors for illness severity among pregnant women with confirmed SARS-CoV-2 infection – Surveillance for Emerging Threats to Mothers and Babies Network, 22 state, local, and territorial health departments, March 29, 2020 -March 5, 2021

Author

Galang, Romeo R, Newton, Suzanne M, Woodworth, Kate R, Griffin, Isabel, Oduyebo, Titilope, Sancken, Christina L, Olsen, Emily O'Malley, Aveni, Kathryn, Wingate, Heather, Shephard, Hanna, Fussman, Chris, Alaali, Zahra S, Silcox, Kristin, Siebman, Samantha, Halai, Umme-Aiman, Lopez, Camille Delgado, Lush, Mamie, Sokale, Ayomide, Barton, Jerusha, Chaudhary, Ifrah, Patrick, Paul H, Schlosser, Levi, Reynolds, Bethany, Gaarenstroom, Nicole, Chicchelly, Sarah, Read, Jennifer S, de Wilde, Leah, Mbotha, Deborah, Azziz-Baumgartner, Eduardo, Hall, Aron J, Tong, Van T, Ellington, Sascha, and Gilboa, Suzanne M

Subjects
Adult, SARS-CoV-2, COVID-19, Mothers, macromolecular substances, AcademicSubjects/MED00290, illness severity, Pregnancy, Risk Factors, Humans, Supplement Article, Female, Pregnant Women, Pregnancy Complications, Infectious, Aged
Abstract

Background Pregnant women with coronavirus disease 2019 (COVID-19) are at increased risk for severe illness compared with nonpregnant women. Data to assess risk factors for illness severity among pregnant women with COVID-19 are limited. This study aimed to determine risk factors associated with COVID-19 illness severity among pregnant women with SARS-CoV-2 infection. Methods Pregnant women with SARS-CoV-2 infection confirmed by molecular testing were reported during March 29, 2020–March 5, 2021 through the Surveillance for Emerging Threats to Mothers and Babies Network (SET-NET). Criteria for illness severity (asymptomatic, mild, moderate-to-severe, or critical) were adapted from National Institutes of Health and World Health Organization criteria. Crude and adjusted risk ratios for moderate-to-severe or critical COVID-19 illness were calculated for selected demographic and clinical characteristics. Results Among 7,950 pregnant women with SARS-CoV-2 infection, moderate-to-severe or critical COVID-19 illness was associated with age 25 years and older, healthcare occupation, pre-pregnancy obesity, chronic lung disease, chronic hypertension, and pregestational diabetes mellitus. Risk of moderate-to-severe or critical illness increased with the number of underlying medical or pregnancy-related conditions. Conclusions Older age and having underlying medical conditions were associated with increased risk of moderate-to-severe or critical COVID-19 illness among pregnant women. This information might help pregnant women understand their risk for moderate-to-severe or critical COVID-19 illness and inform targeted public health messaging.

Published
2021

Catalog

Books, media, physical & digital resources
See catalog results